Insider · CIK 0001252240

SCHOENHARD GRANT

Reports to the SEC for 1 company

sec.gov

Transactions

Companies

Filings

CIK

0001252240

Forms 4 and 5

Insider transactions

47 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2014-07-11	FLNAFILANA THERAPEUTICS, INC.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+129K sh	$4.54	+$584K	195,874
2014-07-11	FLNAFILANA THERAPEUTICS, INC.F Tax Payment	Chief Scientific Officer	FTax Payment	−117K sh	$4.98	−$584K	78,551
2014-07-11	FLNAFILANA THERAPEUTICS, INC. · Common StockM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−129K sh	$4.54	−$584K	1,001,880
2013-06-05	FLNAFILANA THERAPEUTICS, INC. · Stock Options (1)A Award	Chief Scientific Officer	AAward	+150K sh	$2.41	+$362K	1,272,489
2013-05-01	FLNAFILANA THERAPEUTICS, INC.J Other	Chief Scientific Officer	JOther	+650 sh	$1.92	+$1,248	67,181
2012-10-16	FLNAFILANA THERAPEUTICS, INC.A Award	Chief Scientific Officer	AAward	+11K sh	—	—	66,531
2012-06-08	FLNAFILANA THERAPEUTICS, INC. · Stock Option (1)A Award	Chief Scientific Officer	AAward	+70K sh	$4.36	+$305K	924,212
2011-06-01	FLNAFILANA THERAPEUTICS, INC. · Common StockA Award	Chief Scientific Officer	AAward	+70K sh	$10.00	+$700K	887,024
2011-02-28	FLNAFILANA THERAPEUTICS, INC.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+67.6K sh	$6.10	+$412K	115,779
2011-02-28	FLNAFILANA THERAPEUTICS, INC.F Tax Payment	Chief Scientific Officer	FTax Payment	−60.3K sh	$6.84	−$412K	55,499
2011-02-28	FLNAFILANA THERAPEUTICS, INC. · Common StockM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−67.6K sh	$6.10	−$412K	817,024
2010-09-09	FLNAFILANA THERAPEUTICS, INC. · Common StockA Award	Chief Scientific Officer	AAward	+70K sh	$5.83	+$408K	724,000
2010-07-16	FLNAFILANA THERAPEUTICS, INC.X Exercise of In-Money	Chief Scientific Officer	XExercise of In-Money	+1,500 sh	$4.40	+$6,600	49,687
2010-07-16	FLNAFILANA THERAPEUTICS, INC.S Sale	Chief Scientific Officer	SSale	−1,500 sh	$5.54	−$8,310	48,157
2010-07-16	FLNAFILANA THERAPEUTICS, INC. · Common StockX Exercise of In-Money	Chief Scientific Officer	XExercise of In-Money	+1,500 sh	$4.40	+$6,600	654,000
2010-06-16	FLNAFILANA THERAPEUTICS, INC.X Exercise of In-Money	Chief Scientific Officer	XExercise of In-Money	+1,500 sh	$4.40	+$6,600	49,687
2010-06-16	FLNAFILANA THERAPEUTICS, INC.S Sale	Chief Scientific Officer	SSale	−1,500 sh	$5.45	−$8,175	48,187
2010-06-16	FLNAFILANA THERAPEUTICS, INC. · Common StockX Exercise of In-Money	Chief Scientific Officer	XExercise of In-Money	−1,500 sh	$4.40	−$6,600	655,500
2010-05-27	FLNAFILANA THERAPEUTICS, INC.X Exercise of In-Money	Chief Scientific Officer	XExercise of In-Money	+11K sh	$5.25	+$57.6K	59,166
2010-05-27	FLNAFILANA THERAPEUTICS, INC.S Sale	Chief Scientific Officer	SSale	−11K sh	$5.74	−$63K	48,187
2010-05-27	FLNAFILANA THERAPEUTICS, INC. · Common StockX Exercise of In-Money	Chief Scientific Officer	XExercise of In-Money	−11K sh	$5.25	−$57.6K	657,000
2010-05-19	FLNAFILANA THERAPEUTICS, INC.X Exercise of In-Money	Chief Scientific Officer	XExercise of In-Money	+2,486 sh	$5.25	+$13.1K	50,673
2010-05-19	FLNAFILANA THERAPEUTICS, INC.S Sale	Chief Scientific Officer	SSale	−2,486 sh	$5.77	−$14.3K	48,187
2010-05-19	FLNAFILANA THERAPEUTICS, INC. · Common StockX Exercise of In-Money	Chief Scientific Officer	XExercise of In-Money	+2,486 sh	$5.25	+$13.1K	667,979
2010-05-18	FLNAFILANA THERAPEUTICS, INC.X Exercise of In-Money	Chief Scientific Officer	XExercise of In-Money	+7,926 sh	$5.25	+$41.6K	61,222
2010-05-18	FLNAFILANA THERAPEUTICS, INC.S Sale	Chief Scientific Officer	SSale	−7,926 sh	$5.78	−$45.8K	48,187
2010-05-18	FLNAFILANA THERAPEUTICS, INC. · Common StockX Exercise of In-Money	Chief Scientific Officer	XExercise of In-Money	+7,926 sh	$5.25	+$41.6K	670,465
2010-05-17	FLNAFILANA THERAPEUTICS, INC.X Exercise of In-Money	Chief Scientific Officer	XExercise of In-Money	+1,500 sh	$4.40	+$6,600	49,687
2010-05-17	FLNAFILANA THERAPEUTICS, INC.X Exercise of In-Money	Chief Scientific Officer	XExercise of In-Money	+3,609 sh	$5.25	+$18.9K	53,296
2010-05-17	FLNAFILANA THERAPEUTICS, INC.S Sale	Chief Scientific Officer	SSale	−5,109 sh	$5.75	−$29.4K	5,611
2010-05-17	FLNAFILANA THERAPEUTICS, INC. · Common StockX Exercise of In-Money	Chief Scientific Officer	XExercise of In-Money	+1,500 sh	$4.40	+$6,600	682,000
2010-05-17	FLNAFILANA THERAPEUTICS, INC. · Common StockX Exercise of In-Money	Chief Scientific Officer	XExercise of In-Money	+3,609 sh	$5.25	+$18.9K	678,391
2010-04-16	FLNAFILANA THERAPEUTICS, INC.X Exercise of In-Money	Chief Scientific Officer	XExercise of In-Money	+1,500 sh	$4.40	+$6,600	49,687
2010-04-16	FLNAFILANA THERAPEUTICS, INC.X Exercise of In-Money	Chief Scientific Officer	XExercise of In-Money	+25K sh	$5.25	+$131K	74,687
2010-04-16	FLNAFILANA THERAPEUTICS, INC.S Sale	Chief Scientific Officer	SSale	−26.5K sh	$6.29	−$167K	48,187
2010-04-16	FLNAFILANA THERAPEUTICS, INC. · Common StockX Exercise of In-Money	Chief Scientific Officer	XExercise of In-Money	−1,500 sh	$4.40	−$6,600	708,500
2010-04-16	FLNAFILANA THERAPEUTICS, INC. · Common StockX Exercise of In-Money	Chief Scientific Officer	XExercise of In-Money	−25K sh	$5.25	−$131K	683,500
2010-03-16	FLNAFILANA THERAPEUTICS, INC.P Purchase	Chief Scientific Officer	PPurchase	+10K sh	$4.40	+$44K	58,187
2010-03-16	FLNAFILANA THERAPEUTICS, INC.P Purchase	Chief Scientific Officer	PPurchase	+25K sh	$5.25	+$131K	83,187
2010-03-16	FLNAFILANA THERAPEUTICS, INC.S Sale	Chief Scientific Officer	SSale	−35K sh	$6.13	−$214K	48,187
2010-03-16	FLNAFILANA THERAPEUTICS, INC. · Common StockX Exercise of In-Money	Chief Scientific Officer	XExercise of In-Money	−25K sh	$5.25	−$131K	720,000
2010-03-16	FLNAFILANA THERAPEUTICS, INC. · Common StockX Exercise of In-Money	Chief Scientific Officer	XExercise of In-Money	−10K sh	$4.40	−$44K	710,000
2009-07-31	FLNAFILANA THERAPEUTICS, INC. · Stock OptionA Award	Chief Scientific Officer	AAward	+70K sh	$4.40	+$308K	745,000
2007-06-08	FLNAFILANA THERAPEUTICS, INC. · Stock OptionsA Award	Chief Scientific Officer	AAward	+75K sh	$8.25	+$619K	600,000
2006-06-09	FLNAFILANA THERAPEUTICS, INC. · Stock OptionsA Award	Chief Scientific Officer	AAward	+75K sh	$8.35	+$626K	525,000
2005-05-31	FLNAFILANA THERAPEUTICS, INC. · Stock OptionsA Award	Chief Scientific Officer	AAward	+75K sh	$5.25	+$394K	450,000
2005-05-31	FLNAFILANA THERAPEUTICS, INC. · Stock OptionsA Award	Chief Scientific Officer	AAward	+75K sh	$5.25	+$394K	475,000

Recent filings

Accepted (ET)
Jul 154
PAIN THERAPEUTICS INC0001573723-14-000020
SEC(opens sec.gov)
Jun 104
PAIN THERAPEUTICS INC0001573723-13-000015
SEC(opens sec.gov)
May 64
SCHOENHARD GRANT0001573723-13-000003
SEC(opens sec.gov)
Oct 174
SCHOENHARD GRANT0001245261-12-000016
SEC(opens sec.gov)
Jun 254
SCHOENHARD GRANT0001245261-12-000011
SEC(opens sec.gov)
Jun 84
SCHOENHARD GRANT0001245261-11-000018
SEC(opens sec.gov)
Mar 154
SCHOENHARD GRANT0001245261-11-000005
SEC(opens sec.gov)
Sep 104
SCHOENHARD GRANT0001245261-10-000039
SEC(opens sec.gov)
Jul 204
SCHOENHARD GRANT0001245261-10-000032
SEC(opens sec.gov)
Jun 174
SCHOENHARD GRANT0001245261-10-000029
SEC(opens sec.gov)
Jun 14
SCHOENHARD GRANT0001245261-10-000023
SEC(opens sec.gov)

Companies

FILANA THERAPEUTICS, INC.Chief Scientific OfficerFLNA